Subtype
Malignant Urinary Tract Neoplasm
CI-CAN-00003252Explore in graph →
507 active trials14 approved drugs29 evidence items
- NCIt
- C192668
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003252Explore in graph →
Clinical trials
1,954 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (246)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06440018 | INSPIRE: a Multi-Cancer Early Detection Study(INSPIRE) | unknown | — | 5,350 | Singlera Genomics Inc.INDUSTRY | 1 | Feb 21, 2025 | clinicaltrials |
| NCT05337189 | A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China | unknown | — | 482 | Creative Biosciences (Guangzhou) Co., Ltd.INDUSTRY | 1 | Feb 13, 2025 |
| clinicaltrials |
| NCT04660929 | CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | unknown | Phase 1 | 48 | Carisma Therapeutics IncINDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT03108196 | Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal Neobladder | unknown | N/A | 96 | Zhujiang HospitalOTHER | 1 | Dec 4, 2024 | clinicaltrials |
| NCT06565923 | Study on the Staging and Prognosis Model of Bladder Cancer(2024-SR-386) | unknown | — | 200 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT05229614 | Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease(ICONIC) | unknown | Phase 2 | 27 | CNAO National Center of Oncological HadrontherapyOTHER | 2 | Aug 21, 2024 | clinicaltrials |
| NCT06564363 | The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma | unknown | — | 148 | Wuhan Ammunition Life-tech Co., LtdINDUSTRY | 1 | Aug 21, 2024 | clinicaltrials |
| NCT06215976 | The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer | unknown | Phase 4 | 78 | Cairo UniversityOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT05867303 | A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors | unknown | Phase 1 | 48 | RemeGen Co., Ltd.INDUSTRY | 2 | Aug 16, 2024 | clinicaltrials |
| NCT06550947 | ALDOA Expression in Bladder Urothelial Carcinoma | unknown | — | 50 | Assiut UniversityOTHER | 0 | Aug 13, 2024 | clinicaltrials |
| NCT06551233 | Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC) | unknown | Phase 1 | 30 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT06541821 | Physical Activity, Kinesiophobia, and Stoma Compliance in Urostomy Patients | unknown | — | 30 | Selcuk UniversityOTHER | 1 | Aug 7, 2024 | clinicaltrials |
| NCT05822934 | Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer | unknown | Phase 3 | 20 | Assiut UniversityOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT03362801 | SArcopenia, Mobility, PHYsical Activity and Post-operative Risk of Bladder Carcinoma in the Elderly(SAMPHYR) | unknown | N/A | 69 | University Hospital, CaenOTHER | 1 | Jul 19, 2024 | clinicaltrials |
| NCT06427993 | Urine DNA Methylation Detection for Hematuria Evaluation | unknown | — | 71 | Changhai HospitalOTHER | 1 | Jun 20, 2024 | clinicaltrials |
| NCT06427291 | Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients | unknown | Phase 1 | 20 | Fudan UniversityOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT06416319 | Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct)(PreAct) | unknown | N/A | 164 | Universitätsmedizin MannheimOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT04486781 | A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma | unknown | Phase 2 | 38 | Vasgene Therapeutics, IncINDUSTRY | 1 | May 2, 2024 | clinicaltrials |
| NCT06374914 | Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients | unknown | — | 120 | Dokuz Eylul UniversityOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT05204199 | Role of Microbiome in BCG Responsiveness Prediction(SILENTEMPIRE) | unknown | — | 120 | Cédric PoyetOTHER | 1 | Apr 5, 2024 | clinicaltrials |
| NCT05311618 | Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors | unknown | Phase 1 | 71 | NGM Biopharmaceuticals, IncINDUSTRY | 1 | Apr 1, 2024 | clinicaltrials |
| NCT06334406 | Antitumor T Cell Responses in Patients With Bladder Cancer(immunoBLAD) | unknown | — | 33 | Centre Hospitalier Universitaire de BesanconOTHER | 0 | Mar 28, 2024 | clinicaltrials |
| NCT06324058 | Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC | unknown | N/A | 190 | Huashan HospitalOTHER | 0 | Mar 21, 2024 | clinicaltrials |
| NCT06321640 | Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.(POSITive) | unknown | — | 265 | European Institute of OncologyOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT03549715 | NEoadjuvant Dose-dense MVAC In cOmbination With Durvalumab and Tremelimumab in Muscle-invasive Urothelial Carcinoma(NEMIO) | unknown | Phase 1 / Phase 2 | 121 | Association Pour La Recherche des Thérapeutiques Innovantes en CancérologieOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT06294054 | Bladder Cancer and Neoadjuvant Chemotherapy Efficiency Before Cystectomy(SELECT) | unknown | — | 707 | University Hospital, RouenOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT05710159 | The iBlad App - a National, Exploratory Study on a Multimodality Smartphone App for Bladder Cancer Patients(iBLAD-app) | unknown | — | 100 | Odense University HospitalOTHER | 1 | Mar 1, 2024 | clinicaltrials |
| NCT06032910 | Surgical Mesh in Radical Cystectomy to Prevent Parastomal Hernias | unknown | N/A | 25 | Charles University, Czech RepublicOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT04492293 | An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer | unknown | Phase 2 | 115 | Beijing InnoCare Pharma Tech Co., Ltd.INDUSTRY | 1 | Feb 26, 2024 | clinicaltrials |
| NCT04567719 | Measuring Taste Perception During Chemotherapy for Muscle Invasive Bladder Cancer | unknown | — | 9 | University of Kansas Medical CenterOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT05297552 | A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder Cancer | unknown | Phase 2 | 40 | RemeGen Co., Ltd.INDUSTRY | 1 | Feb 20, 2024 | clinicaltrials |
| NCT06253091 | Comparison of the Application of Robot-assisted Laparoscopic Pathways in Radical Cystectomy | unknown | N/A | 50 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT03924466 | Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients(VUBAR) | unknown | Phase 2 | 55 | Universitair Ziekenhuis BrusselOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT05829057 | The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1 | unknown | Phase 1 | 10 | Zhejiang UniversityOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT04149691 | Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies | unknown | Phase 1 | 42 | Celon Pharma SAINDUSTRY | 1 | Feb 7, 2024 | clinicaltrials |
| NCT06245759 | The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients | unknown | — | 120,000 | Huazhong University of Science and TechnologyOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT06235268 | Prospective and Multicenter Italian Registry of Locally Advanced-Metastatic Urothelial Carcinoma | unknown | — | 1,000 | Federation of Italian Cooperative Oncology GroupsOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT05193656 | Bladder Cancer Detection Using Convolutional Neural Networks(BLAInostic) | unknown | — | 5,000 | Zealand University HospitalOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT06221774 | Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors | unknown | Phase 1 / Phase 2 | 42 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT04994197 | Urothelial Tumor Risk Genes Detection With Genetron Uro V1 and LC-WGS | unknown | — | 970 | Ruijin HospitalOTHER | 1 | Jan 10, 2024 | clinicaltrials |
| NCT06178601 | A Study of RC48-ADC Combined With Cadonilimab（AK104）in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma | unknown | Phase 2 | 36 | Shanxi Province Cancer HospitalOTHER | 1 | Dec 21, 2023 | clinicaltrials |
| NCT02969083 | Feasibility of Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma(URANUS) | unknown | Phase 2 | 200 | The European Uro-Oncology GroupOTHER | 3 | Dec 18, 2023 | clinicaltrials |
| NCT06152666 | Day-case Endourology; Enablers, Barriers, Unexpected Outcomes | unknown | — | 15 | Royal Devon and Exeter NHS Foundation TrustOTHER | 1 | Dec 1, 2023 | clinicaltrials |
| NCT06152679 | Day-case Endourology; Patient Experience | unknown | — | 15 | Royal Devon and Exeter NHS Foundation TrustOTHER | 1 | Dec 1, 2023 | clinicaltrials |
| NCT06153849 | Analyzing the Urine During BCG Instillation in Bladder Cancer Patients for Disease Followup | unknown | — | 100 | Changhai HospitalOTHER | 1 | Dec 1, 2023 | clinicaltrials |
| NCT06120413 | 18F-LN1 PET/CT in Urothelial Carcinomas | unknown | — | 30 | Sichuan Provincial People's HospitalOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT06115434 | Comparing Operative, Postoperative and Quality of Life of Patients After Salvage and Radical Cystectomy | unknown | — | 80 | Assiut UniversityOTHER | 1 | Nov 3, 2023 | clinicaltrials |
| NCT06113367 | Immunotherapy in Upper Tract Urothelial Carcinoma(VESUVIO) | unknown | — | 350 | Assistance Publique - Hôpitaux de ParisOTHER | 0 | Nov 2, 2023 | clinicaltrials |
| NCT04155359 | Clinical Evaluation of the miR Sentinel BCa™ Test to Diagnose Bladder Cancer in Hematuria Patients | unknown | — | 444 | miR Scientific LLCINDUSTRY | 1 | Oct 25, 2023 | clinicaltrials |
| NCT05259319 | Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT)(IMMUNOs-SBRT) | unknown | Phase 1 | 92 | Centre Georges Francois LeclercOTHER | 1 | Oct 17, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Feb 21, 2025source: clinicaltrials